摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-dioctylthymine | 869006-25-7

中文名称
——
中文别名
——
英文名称
1,3-dioctylthymine
英文别名
5-Methyl-1,3-dioctylpyrimidine-2,4-dione
1,3-dioctylthymine化学式
CAS
869006-25-7
化学式
C21H38N2O2
mdl
——
分子量
350.545
InChiKey
DEPXTBUASVAFFM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.6
  • 重原子数:
    25
  • 可旋转键数:
    14
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    40.6
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1,3-dioctylthymine2,6-二甲基吡啶 、 dipotassium peroxodisulfate 、 硫酸 、 copper(II) sulfate 作用下, 以 乙腈 为溶剂, 反应 1.0h, 以60%的产率得到5-formyl-1,3-dioctyluracil
    参考文献:
    名称:
    wittig烯化合成5-取代的尿嘧啶和2,4-二甲氧基嘧啶
    摘要:
    高纯度的各种新的5-烯基尿嘧啶是通过将稳定化的5-甲酰基-1-辛基-尿嘧啶,5-甲酰基-1,3-二辛基尿嘧啶和5-甲酰基-2,4-二甲氧基嘧啶进行Wittig烯化反应而制得的。半稳定的磷化氢。基于1 H NMR光谱数据讨论产物的构象。
    DOI:
    10.1002/jhet.5570420615
  • 作为产物:
    描述:
    1-溴辛烷胸腺嘧啶 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 5.0h, 以50%的产率得到1,3-dioctylthymine
    参考文献:
    名称:
    wittig烯化合成5-取代的尿嘧啶和2,4-二甲氧基嘧啶
    摘要:
    高纯度的各种新的5-烯基尿嘧啶是通过将稳定化的5-甲酰基-1-辛基-尿嘧啶,5-甲酰基-1,3-二辛基尿嘧啶和5-甲酰基-2,4-二甲氧基嘧啶进行Wittig烯化反应而制得的。半稳定的磷化氢。基于1 H NMR光谱数据讨论产物的构象。
    DOI:
    10.1002/jhet.5570420615
点击查看最新优质反应信息

文献信息

  • C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells
    作者:Eleonora Brognara、Ilaria Lampronti、Giulia Breveglieri、Alessandro Accetta、Roberto Corradini、Alex Manicardi、Monica Borgatti、Alessandro Canella、Chiara Multineddu、Rosangela Marchelli、Roberto Gambari
    DOI:10.1016/j.ejphar.2011.09.024
    日期:2011.12
    The K562 cell line has been proposed as a useful experimental system to identify anti-tumor compounds acting by inducing terminal erythroid differentiation. K562 cells exhibit a low proportion of hemoglobin-synthesizing cells under standard cell growth conditions, but are able to undergo terminal erythroid differentiation when treated with a variety of anti-tumor compounds. In this paper we report a screening study on a set of different modified C(5) uracil derivatives for the evaluation of their antiproliferative effect in connection with erythroid differentiation pathways, and for defining a new class of drug candidates for the treatment of chronic myelogenous leukemia. Activity of the derivatives tested can be classified in two effect: an antiproliferative effect linked to a high level of erythroid differentiation activity and an antiproliferative effect without activation of gamma globin genes The highest antiproliferative effect and erythroid induction was shown by compound 9, a thymine derivative bearing a n-octyl chain on nitrogen N(1), whereas thymine did not show any effect, suggesting the importance of the linear alkyl chain in position N(1). To our knowledge this compound should be considered among the most efficient inducers of erythroid differentiation of K562 cells. This work is the starting point for the quest of more effective and specific drugs for the induction of terminal erythroid differentiation, for leading new insights in the treatment of neoplastic diseases with molecules acting by inducing differentiation rather than by simply exerting cytotoxic effects. (C) 2011 Elsevier B.V. All rights reserved.
  • Synthesis of 5-substituted uracils and 2,4-dimethoxypyrimidines by wittig olefination
    作者:Evdoxia Coutouli-Argyropoulou、Christina Zachariadou
    DOI:10.1002/jhet.5570420615
    日期:2005.9
    A variety of new 5-alkenyluracils has been prepared in high yields by Wittig olefination of 5-formyl-1-octy-luracil, 5-formyl-1,3-dioctyluracil and 5-formyl-2,4-dimethoxy pyrimidine with stabilized and semistabi-lized phosphorus ylides. The conformation of the products is discussed on the basis of 1H NMR spectral data.
    高纯度的各种新的5-烯基尿嘧啶是通过将稳定化的5-甲酰基-1-辛基-尿嘧啶,5-甲酰基-1,3-二辛基尿嘧啶和5-甲酰基-2,4-二甲氧基嘧啶进行Wittig烯化反应而制得的。半稳定的磷化氢。基于1 H NMR光谱数据讨论产物的构象。
查看更多